Table 2.

Clinical characteristics in patients with a respiratory virus identified. Hospital Tobon Uribe, 2007–2012

	Flu A (A)		Flu B (B)		Adeno (C)		RSV (D)		Paraflu (E)
	Count	%	Count	%	Count	%	Count	%	Count	%
Total	276	100·0	150	100·0	141	100·0	18	100·0	110	100·0
Gender
Female	124	44·9	70	46·7	66	46·8	11	61·1	32	29·1
Male	152	55·1	80	53·3	75	53·2	7	38·9	78	70·9
Signs & symptoms*
Cough	260/276	94·2	136/150	90·7	125/141	88·7	18/18	100·0	105/110	95·5
Rhinorrhea	159/276	57·6	83/150	55·3	94/141	66·7	17/18	94·4% A B	68/110	61·8
Pharyngeal erythema	133/263	50·6	70/142	49·3	67/132	50·8	5/15	33·3	46/100	46·0
Headache	91/276	33% C E	35/150	23·3	24/141	17·0	1/18	5·6	11/110	10·0
Sore throat	60/276	21·7	27/150	18·0	25/141	17·7	0/18	0·0	12/110	10·9
Rhonchi	59/276	21·4	37/150	24·7	38/141	27·0	6/18	33·3	25/110	22·7
Myalgia	57/276	20·7% C E	33/150	22·0 C E	12/141	8·5	2/18	11·1	4/110	3·6
Conjunctival irritation	54/276	19·6	27/150	18·0	22/141	15·6	3/18	16·7	16/110	14·5
Vomit	39/263	14·8	10/142	7·0	29/132	22·0 B	2/15	13·3	18/100	18·0
Wheezing	39/276	14·1	24/150	16·0	24/141	17·0	7/18	38·9	27/110	24·5
Abdominal pain	33/263	12·5	19/142	13·4	22/132	16·7	0/15	0·0	8/100	8·0
Dyspnea	25/263	9·5	6/142	4·2	15/132	11·4	5/15	33·3% B	19/100	19·0% B
Expectoration	24/263	9·1	7/142	4·9	8/132	6·1	2/15	13·3	9/100	9·0
Adenopathy	23/263	8·7	9/142	6·3	17/132	12·9	2/15	13·3	6/100	6·0
Diarrhea	21/263	8·0	6/142	4·2	12/132	9·1	0/15	0·0	3/100	3·0
Tachypnea	15/263	5·7	6/142	4·2	13/132	9·8	6/15	40·0 A B C	13/100	13·0
Rales	13/263	4·9	3/142	2·1	7/132	5·3	3/15	20·0	11/100	11·0

Each virus was identified with a letter (A, B, C, D, E), which was inserted next to the virus compared to others, when statistically significance was detected.

^*Excluded: coinfections.